Search Saint Luke's

Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.

Darren Bass, DPT, FACHE, has been named Chief Executive Officer for Saint Luke’s North Region.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.

Nellie Jo Gaston received a lifesaving surgery after an abnormal result from an at-home colon cancer screening test. After treatment at Saint Luke’s, she is cancer-free.

Tony Torchia, an 84-year-old grandfather in Overland Park, has been a loyal Saint Luke’s patient for many years. He never expected to be a patient at the Institute he donated to years prior.

Saint Luke's Hospital celebrated a special graduation after one baby spent 73 days in the NICU.

When Jackie, pictured with her son Brooks, was pregnant, she was diagnosed with Stage 4 chronic kidney disease. After Brooks was born and undergoing a kidney transplant, Jackie is back to enjoying life.

In 2023, an emergency colonoscopy led to Michael's diagnosis of stage 3 cancer. Because of his experience, Michael Kathrens, 70, advocates for proactive health screenings and being an advocate for your own health.